121 results
Page 3 of 7
8-K
EX-99.1
xdfcbhd5c44kbvqf4w
22 Jun 23
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
5:20pm
8-K
EX-99.1
vsgg gdbhhsu
11 May 23
Aeglea BioTherapeutics Reports First Quarter 2023 Financial Results
7:01am
PRE 14A
eejdm4e6 h7bw6y
7 Apr 23
Preliminary proxy
4:02pm
8-K
EX-99.1
i0dpcalqjtmchro4aj
3 Nov 22
Aeglea BioTherapeutics Reports Third Quarter 2022 Financial Results and Provides Program Updates
7:02am
8-K
EX-99.1
gxd 7dwvr
4 Aug 22
Aeglea BioTherapeutics Reports Second Quarter 2022 Financial Results and Provides Program Updates
6:01am
424B5
fga9so dusw15rac
20 May 22
Prospectus supplement for primary offering
4:02pm
424B5
yptydo8ofs0g kwirdzq
6 May 22
Prospectus supplement for primary offering
7:15am
8-K
s6zn3kl1 xcc2p
6 May 22
Entry into a Material Definitive Agreement
6:02am
FWP
euw8t nmn9ta2
5 May 22
Free writing prospectus
4:06pm
8-K
EX-99.1
4dod l51lzm9h
5 May 22
Aeglea BioTherapeutics Reports First Quarter 2022 Financial Results and Provides Program Updates
6:34am
8-K
EX-99.1
slq8z8tg
8 Mar 22
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Program Updates
7:04am
424B5
5xx1lnw
9 Feb 22
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
ryiesos3irq1vf
4 Nov 21
Aeglea BioTherapeutics Reports Third Quarter 2021 Financial Results and Corporate Highlights
7:01am